Bibliography
- Riehemann K , SchneiderS, W Luger, TA, Godin B, Ferrari M, Fuchs H: Nanomedicine – challenge and perspectives. Ang. Chem. Int. Ed.48, 872–897 (2009).
- Ferrari M : Cancer nanotechnology: opportunities and challenges.Nat. Rev. Cancer5, 161–171 (2005).
- Lee CC , MacKayJA, FréchetJMJ, SzokaFC: Designing dendrimers for biological applications.Nat. Biotechnol.23, 1517–1526 (2005).
- Davis ME , ZuckermanJE, ChoiCHJet al.: Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.Nature464, 1067–1070 (2010).
- Jesorka A , OrwarOL: Liposomes: technologies and analytical applications.Annu. Rev. Anal. Chem.1, 801–832 (2008).
- Harrington KJ , LewanskiCR, NorthcoteADet al.: Phase I–II study of PEGylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer.Ann. Oncol.12, 493–496 (2001).
- Kostarelos K , BiancoA, PratoM: Promises, facts and challenges for carbon nanotubes in imaging and therapeutics.Nat. Nanotechnol.4, 627–633 (2009).
- Liu Z , ChenK, DavisCet al.: Drug delivery with carbon nanotubes for in vivo cancer treatment.Cancer Res.68, 6652–6660 (2008).
- Berlin JM , LeonardA, PhamTTet al.: Effective drug delivery in vitro and in vivo, by carbon-based nanovectors non-covalently loaded with paclitaxel.ACS Nano4, 4621–4636 (2010).
- Sugahara KN , TeesaluT, KarmaliPPet al.: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.Science328, 1031–1035 (2010).